calcimedica inc glp-1 receptor agonists weight management diabetes treatments GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review GLP-1-directed NMDA receptor antagonism for

The real message is this: If GLP-1 medication is not the right long-term answer for you, there are excellent alternativesand gastric sleeve is one of the strongest among them

Findings from a phase 2 study on petrelintide were presented today at an American Diabetes Association (ADA) conference

3 Note that this consensus algorithm is a guide and that the clinical management of T2DM should always incorporate the patients unique goals, comorbidities, individual response to therapy, and other factors that may introduce unwanted drug interactions or contraindications to a particular therapy or therapies

N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I